Epidemiology of epithelial ovarian cancer.
作者： Penelope M. Webb , Susan J. Jordan
DOI: 10.1016/J.BPOBGYN.2016.08.006
关键词: Oncology 、 Intervention (counseling) 、 Low and middle income countries 、 Epithelial ovarian cancer 、 Internal medicine 、 Cancer 、 Epidemiology of cancer 、 Epidemiology 、 Ovarian cancer 、 Incidence (epidemiology) 、 Medicine
摘要: Globally, ovarian cancer is the seventh most common in women and eighth cause of death, with five-year survival rates below 45%. Although age-standardised are stable or falling high-income countries, they rising many low middle income countries. Furthermore, increasing life-expectancy, number cases diagnosed each year increasing. To control we need to understand causes. This will allow better prediction those at greatest risk for whom screening might be appropriate, while identification potentially modifable causes provides an opportunity intervention reduce rates. In this paper summarise current state knowledge regarding known possible epithelial discuss some main theories carcinogenesis. We also briefly review relationship between lifestyle after a diagnosis cancer.
uq.edu.au
core.ac.uk参考文章(90)
Janet S. Hildebrand, Susan M. Gapstur, Mia M. Gaudet, Peter T. Campbell, Alpa V. Patel, Moderate-to-vigorous physical activity and leisure-time sitting in relation to ovarian cancer risk in a large prospective US cohort Cancer Causes & Control. ,vol. 26, pp. 1691- 1697 ,(2015) , 10.1007/S10552-015-0656-7
Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies Lancet Oncology. ,vol. 13, pp. 946- 956 ,(2012) , 10.1016/S1470-2045(12)70322-4
, Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls The Lancet. ,vol. 371, pp. 303- 314 ,(2008) , 10.1016/S0140-6736(08)60167-1
Joanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, Cezary Cybulski, Rochelle Demsky, Susan L Neuhausen, Charmaine Kim‐Sing, Nadine Tung, Susan Friedman, Leigha Senter, Jeffrey Weitzel, Beth Karlan, Pal Moller, Ping Sun, Steven A Narod, Hereditary Breast Cancer Clinical Study Group, Henry T Lynch, Christian Singer, Charis Eng, Gillian Mitchell, Tomasz Huzarski, Jeanna McCuaig, Kevin Hughes, Gordon Mills, Parviz Ghadirian, Andrea Eisen, Dawna Gilchrist, Joanne L Blum, Dana Zakalik, Tuya Pal, Mary Daly, Barbara Weber, Carrie Snyder, Taya Fallen, Albert Chudley, John Lunn, Talia Donenberg, Raluca N Kurz, Howard Saal, Judy Garber, Gad Rennert, Kevin Sweet, Ruth Gershoni‐Baruch, Christine Rappaport, Edmond Lemire, Dominique Stoppa‐Lyonnet, Olufunmilayo I Olopade, Sofia Merajver, Louise Bordeleau, Carey A Cullinane, Eitan Friedman, Wendy McKinnon, Marie Wood, Daniel Rayson, Wendy Meschino, Jane McLennan, Josephine Wagner Costalas, Robert E Reilly, Susan Vadaparampil, Kenneth Offit, Noah Kauff, Jan Klijn, David Euhus, Ava Kwong, Claudine Isaacs, Fergus Couch, Siranoush Manoukian, Tomasz Byrski, Christine Elser, Seema Panchal, Susan Armel, Sonia Nanda, Kelly Metcalfe, Aletta Poll, Barry Rosen, William D Foulkes, Timothy Rebbeck, Peter Ainsworth, Andre Robidoux, Ellen Warner, Lovise Maehle, Michael Osborne, Gareth Evans, Barbara Pasini, Ophira Ginsburg, Stephanie Cohen, Gorski Bohdan, Anna Jakubowska, Janice Little, None, Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers International Journal of Cancer. ,vol. 137, pp. 1136- 1146 ,(2015) , 10.1002/IJC.29386
, Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies PLoS Medicine. ,vol. 9, pp. e1001200- ,(2012) , 10.1371/JOURNAL.PMED.1001200
S Wilailak, C Vipupinyo, V Suraseranivong, K Chotivanich, C Kietpeerakool, Y Tanapat, S Therasakvichya, S Hamontri, V Linasmita, S Bunyapipat, S Chindavijak, K Ittiwisavakul, N Khemapech, P Suekwattana, D Thanapprapasr, P Lumbiganon, Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study. British Journal of Obstetrics and Gynaecology. ,vol. 119, pp. 672- 677 ,(2012) , 10.1111/J.1471-0528.2012.03298.X
, Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies The Lancet. ,vol. 385, pp. 1835- 1842 ,(2015) , 10.1016/S0140-6736(14)61687-1
Determinants of Ovarian Cancer Risk. II. Inferences Regarding Pathogenesis Journal of the National Cancer Institute. ,vol. 71, pp. 717- 721 ,(1983) , 10.1093/JNCI/71.4.717
Malignant and Benign Ovarian Neoplasms Among Atomic Bomb Survivors, Hiroshima and Nagasaki, 1950–80 Journal of the National Cancer Institute. ,vol. 79, pp. 47- 57 ,(1987) , 10.1093/JNCI/79.1.47
David C. Whiteman, Penelope M. Webb, Adele C. Green, Rachel E. Neale, Lin Fritschi, Christopher J. Bain, D. Max Parkin, Louise F. Wilson, Catherine M. Olsen, Christina M. Nagle, Nirmala Pandeya, Susan J. Jordan, Annika Antonsson, Bradley J. Kendall, Maria Celia B. Hughes, Torukiri I. Ibiebele, Kyoko Miura, Susan Peters, Renee N. Carey, Cancers in Australia in 2010 attributable to modifiable factors: Summary and conclusions Australian and New Zealand Journal of Public Health. ,vol. 39, pp. 477- 484 ,(2015) , 10.1111/1753-6405.12471